Tagged Articles

migraines 10 articles

Lawsuits allege Mirena IUD caused brain damage

“I was one of the lucky ones,” writes “Proud Mama Fighting Back,” who describes herself as a “post Mirena survivor,” and chronicles her “Mirena nightmare” on her blogspot site, MyLifeAfterMirena. She says she was lucky because after having the Mirena intrauterine device inserted, she lost most of her vision in her right eye after two months. “I went from great vision to legally blind in that eye virtually overnight,” she writes. That’s when the blogger learned about a connection between the Mirena IUD and pseudo tumor cerebra (PTC), also known as idiopathic intracranial hypertension (IIH), a type of brain damage in which too ... Read More

Anti-seizure drug Topamax approved for treatment of migraine headaches in teens

Federal drug regulators have approved the anti-seizure drug Topamax, known generically as topiramate, as a prophylaxis treatment for migraine headaches in teenagers ages 12 to 17. It is the first medication to be approved by the Food and Drug Administration (FDA) for adolescents. It is intended to be taken daily to prevent or reduce the frequency of migraines. Topamax first won FDA approval in 1996 to help prevent seizures. It was approved as a migraine prevention for adults in 2004. The expanded indication to include adolescents was based on a clinical trial involving 103 patients ages 12 to 17. Among ... Read More

Woman’s pain, itching, migraines traced to defective metal hip implant

For two years, Paula Spurlock suffered from unexplained pain, itching and migraines and no doctor could seem to find the source. It wasn’t until she underwent a PET scan that it was discovered that the all-metal hip replacement system she received in 2008 was corroding inside her body. Further studies showed that the metal-on-metal device was leeching metal ions into her bloodstream, causing a type of blood poisoning known as metallosis and triggering her unpleasant symptoms. Traditional artificial hips are made with ceramic or plastic parts. The newer, all-metal hip implants were designed so that they could last longer and ... Read More

Anti-seizure drug linked to increased risk of childhood autism when taken during pregnancy

Pregnant women who take the epilepsy drug valproate, also known by the brand name Depacon, may increase the risk of childhood autism and its spectrum disorders in their unborn babies, a new study suggests. Depacon is used to treat epileptic seizures and mania associated with bipolar disorder, as well as to prevent migraines. The drug already has a black box warning for increasing the risk of serious birth defects in fetuses exposed in utero. The drug’s warning label urges women of childbearing age to weigh the benefits of valporate against the risk of fetal injury, such as neural tube defects including ... Read More

FDA approves new extended regime oral contraceptive

Quartette, a new generation of extended regime oral contraceptives, has been approved by the Food and Drug Administration (FDA), Teva Pharmaceuticals announced. The combination levonorgestral/ethinyl estradiol and ethinyl estradiol tablets are designed to minimize breakthrough bleeding between scheduled periods. Breakthrough bleeding is a common side effect with extended regime birth control pills, especially during the first few months, and one of the main reasons why women give up on the pills. The estrogen in Quartette increases at specific points and provides four short, light periods a year. FDA approval is based on a series of clinical trials involving more than ... Read More

New diet drug Qsymia now available by prescription

The much anticipated diet drug Qsymia is officially on the market. Qsymia, made by Vivus, is one of two new weight loss drugs approved earlier this year by the Food and Drug Administration (FDA), becoming the first diet pills cleared by the FDA in more than 13 years. Unlike other drugs for weight loss, Qsymia, and new rival Belviq, are considered “life-long” treatments for obesity and should be used along with a diet and exercise program. Though both help users lose weight, they work in entirely different ways. Belviq contains the active ingredient lorcaserin, which works by activating a part ... Read More

FDA considers approval of diet drug despite birth defects, heart risks

Drug maker Vivus Inc., is hoping to win Food and Drug Administration (FDA) approval for its diet drug Qnexa this week after a rejection in 2010 due to serious health concerns. Experts say the chances of the weight loss drug being cleared are 50-50. Qnexa is a combination of two FDA-approved drugs. One is phentermine, the “safer” part of the fen-phen diet drug that was banned due to heart problems. The other active ingredient is topiramate, a drug used to treat seizures and migraines. Topiramate has side effects that include suicidal thoughts and birth defects. The FDA rejected Qnexa its ... Read More

‘Should I still be on Yasmin?’

“Should I still be on Yasmin?” asks Beth on a Drugs.com forum. The woman has been taking the popular birth control pills for two years and suddenly developed migraines with blurry vision. Soon after, she had knee surgery and developed a very large blood clot in her leg, called a deep vein thrombosis, or DVT. Doctors put her on the blood thinner coumadin and told her to continue taking Yasmin, but Beth is worried. “I’m swelled up like a balloon,” she writes. “Should I really still be on Yasmin?” There are more than 2,000 women across the country who would ... Read More

Anticonvulsants linked to risk of seizures, suicide, violent death

Popular anticonvulsant drugs are getting significant news coverage these days because of reports that the drugs are causing a return of seizures or risk of suicide in some users. Anticonvulsants are used to control seizures, such as in patients with epilepsy or who have suffered traumatic brain injuries. They are sometimes prescribed to patients to manage migraines and bipolar disorder. Generic brands of the anticonvulsant Keppra, known as Levetiracetam, first made headlines when reports began to surface that patients who had their seizures under control with the brand name Keppra began experiencing a return of their seizures and other problems ... Read More

Aspirin plus Reglan shows promise as migraine treatment

A combination of aspirin and the anti-nausea medication metoclopramide, marketed as Reglan, may help patients with migraines find relief from headaches and vomiting within two hours, according to data from 13 clinical trials in which patients published in the Cochrane Database of Systematic Reviews. Patients in the clinical trials were randomly assigned to treat their migraines with either a single dose of 900 to 1,000 milligrams of aspirin, a placebo, or an active drug, usually the prescription migraine drug sumatriptan. Researchers found that 52 percent of aspirin users got at least some pain relief – or a reduction of pain ... Read More